Ocular Manifestations of Inflammatory Bowel Disease

Ocular Manifestations of Chronic Inflammatory Bowel Disease (IBD): Retrospective Study in the Hepato-gastroenterology Department of the Nancy CHRU

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04771039

Enrollment

Registered

2021-02-25

Start date

2013-01-01

Completion date

2020-12-12

Last updated

2021-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases, Ophthalmopathy

Brief summary

Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.

Interventions

OTHERreason for consultation

search in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department

Exclusion criteria

* Minor patients * patients without IBD * patients for whom there is no ophthalmology consultation

Design outcomes

Primary

Measure	Time frame	Description
frequency	baseline	frequency of ocular manifestations in inflammatory bowel disease

Secondary

Measure	Time frame	Description
Number	baseline	Number of uveitis, scleritis and episcleritis; prevalence calculation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026